Biblio Discovery — Demo Discovery Service

3 hasil untuk "Michael D. Howe"

Menampilkan 1–3 · 0,41 detik · RSS

  1. Artikel Jurnal

    Methionine Antagonizes para-Aminosalicylic Acid Activity via Affecting Folate Precursor Biosynthesis in Mycobacterium tuberculosis

    Michael D. Howe; Shannon L. Kordus; Malcolm S. Cole dkk.

    Frontiers in Cellular and Infection Microbiology, Vol. 8 · 2018 · Inggris · DOAJ Scopus

    para-Aminosalicylic acid (PAS) is a second-line anti-tubercular drug that is used for the treatment of drug-resistant tuberculosis (TB). PAS efficacy in the treatment of TB is limited by its lower potency against Mycobacterium tuberculosis relative to many other drugs in the TB treatment arsenal…

  2. Artikel Jurnal

    Essential role of MHC II in the antitubercular efficacy of pyrazinamide

    Elise A. Lamont; Shannon L. Kordus; Michael D. Howe dkk.

    Antimicrobial Agents and Chemotherapy, Vol. 70 No. 2 · 2026 · Inggris · DOAJ Scopus

    ABSTRACT Antibacterial drug mechanisms have traditionally been examined through a drug-pathogen lens, with limited attention to host influences on drug activity. However, growing evidence suggests that the host environment is crucial for antibacterial efficacy. Pyrazinamide (PZA), a key component…

  3. Artikel Jurnal

    Pyrazinamide Susceptibility Is Driven by Activation of the SigE-Dependent Cell Envelope Stress Response in Mycobacterium tuberculosis

    Joshua M. Thiede; Nicholas A. Dillon; Michael D. Howe dkk.

    mBio, Vol. 13 No. 1 · 2022 · Inggris · DOAJ Scopus

    ABSTRACT Pyrazinamide (PZA) plays a crucial role in first-line tuberculosis drug therapy. Unlike other antimicrobial agents, PZA is active against Mycobacterium tuberculosis only at low pH. The basis for this conditional drug susceptibility remains undefined. In this study, we utilized a…